Today's important announcements for Hong Kong stocks are as follows:

1) Company news

$SUNSHINE INS (06963.HK)$: In the previous 11 months, the subsidiary Sunshine Financial Insurance and Sunshine Life received premium income of 43.829 billion yuan and 77.089 billion yuan respectively from the original insurance contract, up 8.51% and 12.6% year-on-year respectively.

$CHENGDU EXPWAY (01785.HK)$: The controlling shareholder won the bid for the construction and operation of the expressway project.

According to the announcement, a consortium composed of Construction Management Group, the controlling shareholder of the company, China Railway City Development Investment Group Co., Ltd. and Chengdu Construction Engineering Group Co., Ltd. participated in the bidding, and the estimated total investment of the project was RMB 18.821 billion. The parties will jointly establish a project company to be responsible for the investment, construction and operation management of the project. The company can exercise acquisition options and preferential purchasing rights in accordance with the relevant agreements of the new anti-competition agreement.

$Q TECH (01478.HK)$: Participate in the private placement of a joint venture company and intend to subscribe for 20 million shares issued by Xinju Technology.

$SINO-OCEAN GP (03377.HK)$: The hearing of the winding-up petition was adjourned.

$JINGRUI HLDGS (01862.HK)$: The High Court ordered that the hearing of the petition be adjourned until January 22, 2025.

$CHINARES PHARMA (03320.HK)$: Affiliated China Resources Pharmaceutical Investments increased its total shareholding of Donga Ejiao by 1%.

$INT MEDICAL (01501.HK)$: It is proposed to acquire a controlling interest in at least 51% of Hangzhou Weiqiang Medical Technology's shares.

2) Dynamics of holdings increase and repurchase

$GCL TECH (03800.HK)$: It is proposed to place up to 1.56 billion shares, with a net raise of approximately HK$1.53 billion.

$ROBOSENSE (02498.HK)$: Completed the placement of 10 million shares, with a net raise of approximately HK$0.271 billion.

$LUYE PHARMA (02186.HK)$: It was increased by a total of 2 million shares by Executive Chairman Liu Dianbo.

$TENCENT (00700.HK)$: Spend HK$0.703 billion to repurchase 1.73 million shares at a repurchase price of HK$405.2-406.

$ANTA SPORTS (02020.HK)$: On December 18, it spent approximately HK$0.209 billion to repurchase 2.6382 million shares.

$AIA (01299.HK)$: Spend HK$61.5578 million to repurchase 1.115 million shares at a repurchase price of HK$54.90-55.55.

$HSBC HOLDINGS (00005.HK)$: Spend HK$85.5793 million to repurchase 1.1428 million shares at a repurchase price of HK$74.6-75.15.

$TIMES ELECTRIC (03898.HK)$: Spend HK$19.5539 million to repurchase 0.6349 million shares at a repurchase price of HK$30.7-31.

$KUAISHOU-W (01024.HK)$: Spend HK$19.6397 million to repurchase 0.43 million shares at a repurchase price of HK$45.45-46.

Edit/Danial